62 related articles for article (PubMed ID: 6187858)
1. Studies on the B lymphoblast antigen No. 1 (BB-1) on a series of Burkitt lymphoma lines differing in the expression of the EBV/C3 receptor complex.
Ehlin-Henriksson B; Clark EA; Jønsson V; Klein G
J Immunol; 1983 May; 130(5):2448-52. PubMed ID: 6187858
[TBL] [Abstract][Full Text] [Related]
2. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
[TBL] [Abstract][Full Text] [Related]
3. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
4. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
5. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma.
Klein G; Yefenof E; Falk K; Westman A
Int J Cancer; 1978 May; 21(5):552-60. PubMed ID: 207646
[TBL] [Abstract][Full Text] [Related]
7. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
8. Correlated expression of a B-lymphocyte-specific glycoprotein (gp27/35) and the EBV receptor/C3 receptor complex in sublines from the same Burkitt lymphoma.
Klein G; Hyman R; Trowbridge I
Int J Cancer; 1979 Jan; 23(1):37-41. PubMed ID: 215562
[TBL] [Abstract][Full Text] [Related]
9. Differences between soluble complement-fixing antigens derived from P3HR-1, RAJI, and Hk-Ly-28 cell lines.
Weliky N; Leaman DH; Kallman BJ
J Natl Cancer Inst; 1975 Mar; 54(3):593-6. PubMed ID: 164559
[TBL] [Abstract][Full Text] [Related]
10. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
[TBL] [Abstract][Full Text] [Related]
11. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
[TBL] [Abstract][Full Text] [Related]
12. Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody.
Simmons JG; Hutt-Fletcher LM; Fowler E; Feighny RJ
J Immunol; 1983 Mar; 130(3):1303-8. PubMed ID: 6337215
[TBL] [Abstract][Full Text] [Related]
13. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
Yamamoto N; Mitsuma T; Vogt A
J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus receptor is distinct from the C3 receptor.
Wells A; Koide N; Stein H; Gerdes J; Klein G
J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
[TBL] [Abstract][Full Text] [Related]
15. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
16. Effect of activation of the Epstein-Barr virus genome on expression of B cell differentiation antigens of Burkitt's lymphoma lines.
Yokochi T; Inoue Y; Iwata H; Miyadai T; Kimura Y
Microbiol Immunol; 1988; 32(9):957-64. PubMed ID: 2850450
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro.
Siegert W; Mönch T; Valet G
Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102
[TBL] [Abstract][Full Text] [Related]
18. Fc and C3 receptor patterns on two EBV- negative Burkitt lymphoma lines during acute exposure to EBV (P3HR-1 substrain).
Jønsson V; Klein G
Eur J Cancer (1965); 1981 Feb; 17(2):161-5. PubMed ID: 6266834
[No Abstract] [Full Text] [Related]
19. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.
Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960
[TBL] [Abstract][Full Text] [Related]
20. Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies.
Wells A; Godal T; Kvaløy S; Steen HB; Klein G
Differentiation; 1982; 22(2):113-9. PubMed ID: 6290303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
